Non-Parametric Mixture Modelling and its Application to Disease Progression Modelling

Dementia is characterised by its progressive degeneration of cognitive abilities. In research cohorts, detailed neuropsychological test batteries are often administered to better understand how cognition changes over time. Understanding cognitive changes in dementia is of great importance, particula...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv
Main Authors Firth, Nicholas C, Oxtoby, Neil P, Primativo, Silvia, Brotherhood, Emily, Young, Alexandra L, Keir Xx Yong, Crutch, Sebastian J, Alexander, Daniel C
Format Paper
LanguageEnglish
Published Cold Spring Harbor Cold Spring Harbor Laboratory Press 10.04.2018
Subjects
Alzheimer's disease
Cognition & reasoning
Cognitive ability
Dementia
Dementia disorders
Neurodegeneration
Neurodegenerative diseases
Neuroimaging
Phenotypes
Online AccessGet full text

Cover

More Information
Summary:Dementia is characterised by its progressive degeneration of cognitive abilities. In research cohorts, detailed neuropsychological test batteries are often administered to better understand how cognition changes over time. Understanding cognitive changes in dementia is of great importance, particularly in determining how structural changes in the brain may affect cognition and in facilitating earlier detection of symptomatic changes. Disease progression models are often applied to these data to understand how a disease changes over time from cross-sectional data or to disease trajectories from large numbers of individuals. Previous disease progression models used to build longitudinal models from cross-sectional data have focused on brain imaging data; however, these models are not directly applicable to cognitive data. Here we use the novel, non-parametric, Kernel Density Estimation Mixture Modelling (KDEMM) approach and demonstrate accurate modelling of the progression of cognitive test data. We found that using KDEMM resulted in more accurate models of disease progression in simulated data compared to Gaussian Mixture Models (GMMs) for the majority of parameters used to simulate the data. When comparing KDEMM and GMM to cognitive data collected in different Alzheimer's Disease subtypes, we found the KDEMM resulted in a model much more in line with clinical phenotype. We anticipate that the KDEMM will be used to integrate cognitive test data, and other non-normally distributed datasets into complex disease progression models.
DOI:10.1101/297978